CARD11 and colorectal carcinoma: As part of this study, two colorectal carcinoma cell lines from different stages of CRC (HCT-116 and HT-29) were used to elucidate some of the molecular mechanisms involved in CARD11 overexpression and the subsequent activation of cellular pathways related to immune response and cancer progression.